Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Viral Central Memory CD8 Veto Cells in Haploidentical Hematopoietic Stem Cell Transplantation

NCT03622788 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03622788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03622788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Viral Central Memory CD8 Veto Cells in Haploidentical Hematopoietic Stem Cell Transplantation
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
August 8, 2019
Completion date
December 1, 2027
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, bone marrow failure, chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, follicular lymphoma, hodgkin lymphoma, mantle cell lymphoma, myelodysplastic syndrome, myeloproliferative neoplasm, non-hodgkin lymphoma, plasma cell myeloma